子宫动脉栓塞术治疗中期妊娠前置胎盘出血的效果观察

Observation on the effect of uterine artery embolization in the treatment of placenta previa hemorrhage in the second trimester of pregnancy

目的分析子宫动脉栓塞术治疗中期妊娠前置胎盘出血的临床效果。方法70例中期妊娠前置胎盘出血患者,以1∶1比例法分为对照组和观察组,各35例。对照组采取传统手术治疗,观察组采取子宫动脉栓塞术治疗。比较两组患者手术康复情况及术后并发症发生情况。结果观察组并发症发生率为8.57%,显著低于对照组的37.14%,差异有统计学意义(P<0.05)。观察组手术时间(8.50±2.30)min、住院时间(5.20±0.80)d均短于对照组的(51.50±6.50)min、(7.50±1.20)d,术中出血量(180.50±30.50)ml少于对照组的(750.50±35.50)ml,差异有统计学意义(P<0.05);两组月经复潮时间比较,差异无统计学意义(P>0.05)。结论采用子宫动脉栓塞术治疗中期妊娠前置胎盘出血效果优于采用传统手术治疗,其可有效减少术中出血量,治疗时间短,且安全性高,值得临床推广。

Objective To analyze the clinical effect of uterine artery embolization in the treatment of placenta previa hemorrhage in the second trimester of pregnancy.Methods A total of 70 patients with placental previa hemorrhage in the second trimester of pregnancy were divided into control group and observation group by 1∶1 ratio,with 35 cases in each group.The control group was treated with traditional surgery,and the observation group was treated with uterine artery embolization.The surgical rehabilitation and postoperative complications were compared between the two groups.Results The complication rates in the observation group was 8.57%,which was significantly lower than 37.14%in the control group,and the difference was statistically significant(P<0.05).The operation time(8.50±2.30)min and hospitalization time(5.20±0.80)d of the observation group were shorter than(51.50±6.50)min and(7.50±1.20)d of the control group,and the intraoperative blood loss(180.50±30.50)ml was less than(750.50±35.50)ml of the control group.All the differences were statistically significant (P<0.05). There was no statistically significant difference in menstrual rehydration time between the two groups (P>0.05). Conclusion Uterine artery embolization for the treatment of placenta previa hemorrhage in the second trimester of pregnancy is more effective than traditional surgical treatment, and it can effectively reduce intraoperative blood loss, shorten treatment time with high safety, which is worthy of clinical promotion.